Metformin Targets Foxo1 to Control Glucose Homeostasis

Metformin is the first-line pharmacotherapy for type 2 diabetes mellitus (T2D). Metformin exerts its glucose-lowering effect primarily through decreasing hepatic glucose production (HGP). However, the precise molecular mechanisms of metformin remain unclear due to supra-pharmacological concentration...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xiaoqin, Li, Xiaopeng, Yang, Wanbao, Liao, Wang, Shen, James Zheng, Ai, Weiqi, Pan, Quan, Sun, Yuxiang, Zhang, Kebin, Zhang, Rui, Qiu, Yuyang, Dai, Qian, Zheng, Hongting, Guo, Shaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231152/
https://www.ncbi.nlm.nih.gov/pubmed/34208360
http://dx.doi.org/10.3390/biom11060873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231152/
https://www.ncbi.nlm.nih.gov/pubmed/34208360
http://dx.doi.org/10.3390/biom11060873

Ejemplares similares